Oncogene-mediated human lung epithelial cell transformation produces adenocarcinoma phenotypes in vivo.
暂无分享,去创建一个
T. Itoh | T. Sukezane | T. Akagi | K. Sasai | E. Yanagita | Harumi Nakagawa | A. Hotta | Ken Sasai
[1] J. Pipas,et al. Transforming functions of Simian Virus 40 , 2001, Oncogene.
[2] L. Kèlland,et al. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. , 2004, European journal of cancer.
[3] H. Hanafusa,et al. v-Crk Activates the Phosphoinositide 3-Kinase/AKT Pathway by Utilizing Focal Adhesion Kinase and H-Ras , 2002, Molecular and Cellular Biology.
[4] Charles A Powell,et al. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. , 2003, The American journal of pathology.
[5] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[6] H. Hanafusa,et al. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. Akagi. Oncogenic transformation of human cells: shortcomings of rodent model systems. , 2004, Trends in molecular medicine.
[8] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[9] Mallika Singh,et al. Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models , 2010, Nature Biotechnology.
[10] K. Roemer,et al. Resistance of mitochondrial p53 to dominant inhibition , 2008, Molecular Cancer.
[11] S. Murata,et al. Expression of Thyroid Transcription Factor-1 in Normal and Neoplastic Lung Tissues , 2002, Modern Pathology.
[12] T. Jacks,et al. Modeling human lung cancer in mice: similarities and shortcomings , 1999, Oncogene.
[13] T. Curran,et al. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies. , 2006, Cancer research.
[14] Jingwei Cheng,et al. Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens. , 2009, Seminars in cancer biology.
[15] Scott H. Randell,et al. Basal cells as stem cells of the mouse trachea and human airway epithelium , 2009, Proceedings of the National Academy of Sciences.
[16] D. Burstein,et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. , 2002, Human pathology.
[17] E. May,et al. Accumulation of an inactive form of p53 protein in cells treated with TNFα , 2002, Cell Death and Differentiation.
[18] M. Meyerson,et al. Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients , 2008, British Journal of Cancer.
[19] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[20] Eran Segal,et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. , 2008, Cell stem cell.
[21] B. Klein,et al. Embryonic stem cell markers expression in cancers. , 2009, Biochemical and biophysical research communications.
[22] R. Eisenman,et al. Myc's broad reach. , 2008, Genes & development.
[23] E. Shaulian,et al. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding , 1992, Molecular and cellular biology.
[24] A. Berns,et al. Mouse models for human lung cancer. , 2005, Genes & development.
[25] J. Minna,et al. Molecular genetics of lung cancer. , 1988, Annual review of medicine.
[26] W. Ryder,et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. , 1996, British Journal of Cancer.
[27] M. Fujita,et al. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. , 2009, Carcinogenesis.
[28] James D Iglehart,et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. , 2007, Cancer cell.
[29] D. Neil Hayes,et al. LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.
[30] W. Hahn,et al. Immortalization and transformation of primary human airway epithelial cells by gene transfer , 2002, Oncogene.
[31] J. Minna,et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. , 2006, Cancer research.
[32] S. Lippman,et al. Lung cancer. , 2008, The New England journal of medicine.
[33] Oliver Gautschi,et al. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. , 2007, Lung Cancer.
[34] William C Hahn,et al. Functional genetics and experimental models of human cancer. , 2004, Trends in molecular medicine.
[35] W. Lam,et al. PIK3CA mutations and copy number gains in human lung cancers. , 2008, Cancer research.
[36] J. Pollack,et al. Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.
[37] Shinya Tanaka,et al. Careful Exclusion of Non-neoplastic Brain Components is Required for an Appropriate Evaluation of O6-methylguanine-DNA Methyltransferase Status in Glioma: Relationship Between Immunohistochemistry and Methylation Analysis , 2008, The American journal of surgical pathology.